The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Trehu Elizabeth since 2018.
This trader's CIK number is 1693456.
At the time of last reporting, Trehu Elizabeth was the Chief Medical Officer of Jounce Therapeutics, Inc.. (stock ticker symbol JNCE).
Also see all insider trading activities at Jounce Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | JNCE | 0 | $0 | 9,285 | $10,315 | 0 | $0 |
| 2022 | JNCE | 0 | $0 | 8,383 | $57,699 | 0 | $0 |
| 2021 | JNCE | 0 | $0 | 25,298 | $250,768 | 20,000 | $80,397 |
| 2020 | JNCE | 0 | $0 | 4,806 | $30,698 | 0 | $0 |
| 2019 | JNCE | 0 | $0 | 2,336 | $9,328 | 0 | $0 |
| 2018 | JNCE | 0 | $0 | 9,090 | $212,409 | 33,965 | $136,537 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-09 | JNCE | Sale | 4,159 | 1.10 | 4,574 |
| 2023-01-10 | JNCE | Sale | 5,126 | 1.12 | 5,741 |
| 2022-01-10 | JNCE | Sale | 5,378 | 6.65 | 35,763 |
| 2022-01-07 | JNCE | Sale | 3,005 | 7.30 | 21,936 |
| 2021-03-31 | JNCE | Sale | 8,300 | 10.09 | 83,747 |
| 2021-03-30 | JNCE | Sale | 100 | 10.00 | 1,000 |
| 2021-03-29 | JNCE | Sale | 5,100 | 10.09 | 51,459 |
| 2021-03-31 | JNCE | Option Ex | 8,300 | 4.02 | 33,366 |
| 2021-03-30 | JNCE | Option Ex | 100 | 4.02 | 401 |
| 2021-03-29 | JNCE | Option Ex | 5,100 | 4.02 | 20,501 |
| 2021-01-20 | JNCE | Sale | 6,500 | 12.01 | 78,065 |
| 2021-01-20 | JNCE | Option Ex | 6,500 | 4.02 | 26,129 |
| 2021-01-07 | JNCE | Sale | 2,452 | 6.76 | 16,575 |
| 2021-01-08 | JNCE | Sale | 2,846 | 7.00 | 19,922 |
| 2020-08-17 | JNCE | Sale | 454 | 4.86 | 2,206 |
| 2020-08-14 | JNCE | Sale | 1,728 | 4.67 | 8,078 |
| 2020-01-07 | JNCE | Sale | 2,624 | 7.78 | 20,414 |
| 2019-08-16 | JNCE | Sale | 1,018 | 3.92 | 3,990 |
| 2019-08-15 | JNCE | Sale | 648 | 4.00 | 2,592 |
| 2019-08-14 | JNCE | Sale | 670 | 4.10 | 2,746 |
| 2018-06-08 | JNCE | Option Ex | 24,875 | 4.02 | 99,997 |
| 2018-03-08 | JNCE | Option Ex | 4,545 | 4.02 | 18,270 |
| 2018-03-08 | JNCE | Sale | 4,545 | 25.06 | 113,897 |
| 2018-03-05 | JNCE | Option Ex | 4,545 | 4.02 | 18,270 |
| 2018-03-05 | JNCE | Sale | 4,545 | 21.68 | 98,512 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Trehu Elizabeth (Chief Medical Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.